Akron Children's > For Families & Patients > Research > Pediatric Clinical Studies > Open Clinical Studies
Peginterferon Alfa-2b in Treating Younger Patients With Craniopharyngioma
Full IRB Study Title:
PBTC-039: Phase II Study of Peginterferon alfa-2b (PEGIntron) for Pediatric Patients with Un-resectable or Recurrent Craniopharyngioma - Cincinnati
IRB Study ID: 141110
For complete information, please visit the study on clinicaltrials.gov
This study is being done in collaboration with Cincinnati Children's Hospital.
